December digital edition 2023

Much has changed in the study of keratoconus over the years.

Although the differential diagnosis of pigmented fundus lesions is limited, the distinctions among these lesions are not always clear.

An overview of current ocular biofilm removal procedures

Etiology is crucial to substantive treatment.

Earlier this year, Aurion’s cell therapy received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency for the management of bullous keratopathy, marking the first regulatory approval in the world for an allogeneic cell therapy to manage corneal endothelial disease.

Noninvasive treatments can help patients with ptosis improve their visual field.

As 2023 draws to a close, it’s the perfect time for practice owners to reflect on the past year’s successes and challenges while gearing up for a fresh start in the new year. Here’s a to-do list that private practice physicians can do in the last 2 weeks of December for a prosperous year ahead.